IRadimed cuts full-year guidance as demand for its 3870 pump grows
IRadimed (IRMD) lowered its full-year guidance after quality issues constrained production ramp-up. Bookings rose on the 3870 pump, and the company declared a $0.20 quarterly dividend.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
IRadimed Corp. (IRMD) lowered its full-year guidance, saying quality concerns slowed the ramp-up of production, according to the company, as reported by TradingView. Demand for its 3870 pump, however, lifted bookings and backlog, as customers replace older units with the four-channel model and new buyers adopt it.
The board declared a quarterly cash dividend of $0.20 per share, with a record date of November 13, 2026 and a payment date of November 27, 2026. No other changes to the dividend were announced.
why it matters
The news is mixed: the guidance cut points to production problems, while rising orders and a steady payout suggest demand remains firm. For the broader market the story is minor, and the main audience is investors in this niche medical equipment segment.
tags
instruments
sources
- Key facts: IRMD trims guidance; 3870 lifts bookings; $0.20 dividend — TradingView, 31 October 2026 at 07:00 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗